Last year, Eyenuk CEO Kaushal Solanki told MedCity News his company is on a mission to “screen every eye in the world” by leveraging its AI-powered disease detection technologies. Eyenuk still has a ...

This is a retrospective analysis of 200 randomly selected patients eligible for diabetic retinopathy screening aged 90 years and over within the Birmingham, Solihull, and Black Country Screening ...

NEW YORK, NY — Screening near-infrared reflectance imaging could identify cases of diabetic retinopathy for early treatment, researchers say. In a retrospective study of near-infrared images acquired ...

—Investigators recently assessed teleretinal screening in a large safety net clinic system in Los Angeles County. Here’s what they found. Reviewed by Sarju Patel, MD MPH MSc, Director of Uveitis and ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

Please provide your email address to receive an email when new articles are posted on . The use of artificial intelligence in screening for diabetic retinopathy led to accurate referrals in Rwanda ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

—Teleretinal screening in the primary care setting has the potential to identify patients who are at risk of vision loss from diabetic retinopathy. Reviewed by Sarju Patel MD MPH MSc, Director, ...

A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability ...

Despite its underutilization, AI-powered diabetic retinopathy screening was associated with greater OCT referral rates than traditional screening methods. Artificial intelligence (AI)-based diabetic ...

AI-based retinal imaging and diagnostics startup AEYE Health announced today it received clearance from the FDA to market its diagnostic screening system for diabetic retinopathy. There are 35 million ...